mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.3 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |